Vaneck Pharmaceutical Etf Market Value
| PPH Etf | USD 88.58 0.64 0.73% |
| Symbol | VanEck |
The market value of VanEck Pharmaceutical ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is VanEck Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Pharmaceutical's market value can be influenced by many factors that don't directly affect VanEck Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
VanEck Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to VanEck Pharmaceutical's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of VanEck Pharmaceutical.
| 10/25/2024 |
| 11/24/2024 |
If you would invest 0.00 in VanEck Pharmaceutical on October 25, 2024 and sell it all today you would earn a total of 0.00 from holding VanEck Pharmaceutical ETF or generate 0.0% return on investment in VanEck Pharmaceutical over 30 days. VanEck Pharmaceutical is related to or competes with VanEck Biotech, VanEck Retail, IShares Healthcare, IShares Telecommunicatio, and VanEck Oil. The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index More
VanEck Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure VanEck Pharmaceutical's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess VanEck Pharmaceutical ETF upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.41) | |||
| Maximum Drawdown | 3.61 | |||
| Value At Risk | (1.46) | |||
| Potential Upside | 0.7429 |
VanEck Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for VanEck Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as VanEck Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use VanEck Pharmaceutical historical prices to predict the future VanEck Pharmaceutical's volatility.| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.25) | |||
| Treynor Ratio | (0.62) |
VanEck Pharmaceutical ETF Backtested Returns
VanEck Pharmaceutical ETF owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.22, which indicates the etf had a -0.22% return per unit of risk over the last 3 months. VanEck Pharmaceutical ETF exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate VanEck Pharmaceutical's Coefficient Of Variation of (468.24), risk adjusted performance of (0.17), and Variance of 0.4346 to confirm the risk estimate we provide. The entity has a beta of 0.24, which indicates not very significant fluctuations relative to the market. As returns on the market increase, VanEck Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding VanEck Pharmaceutical is expected to be smaller as well.
Auto-correlation | 0.49 |
Average predictability
VanEck Pharmaceutical ETF has average predictability. Overlapping area represents the amount of predictability between VanEck Pharmaceutical time series from 25th of October 2024 to 9th of November 2024 and 9th of November 2024 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of VanEck Pharmaceutical ETF price movement. The serial correlation of 0.49 indicates that about 49.0% of current VanEck Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.49 | |
| Spearman Rank Test | 0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 1.58 |
VanEck Pharmaceutical ETF lagged returns against current returns
Autocorrelation, which is VanEck Pharmaceutical etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting VanEck Pharmaceutical's etf expected returns. We can calculate the autocorrelation of VanEck Pharmaceutical returns to help us make a trade decision. For example, suppose you find that VanEck Pharmaceutical has exhibited high autocorrelation historically, and you observe that the etf is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
VanEck Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If VanEck Pharmaceutical etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if VanEck Pharmaceutical etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in VanEck Pharmaceutical etf over time.
Current vs Lagged Prices |
| Timeline |
VanEck Pharmaceutical Lagged Returns
When evaluating VanEck Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of VanEck Pharmaceutical etf have on its future price. VanEck Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, VanEck Pharmaceutical autocorrelation shows the relationship between VanEck Pharmaceutical etf current value and its past values and can show if there is a momentum factor associated with investing in VanEck Pharmaceutical ETF.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether VanEck Pharmaceutical ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Pharmaceutical Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Pharmaceutical Etf:Check out VanEck Pharmaceutical Correlation, VanEck Pharmaceutical Volatility and VanEck Pharmaceutical Alpha and Beta module to complement your research on VanEck Pharmaceutical. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
VanEck Pharmaceutical technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.